1-3 of 3
Ove J. Nielsen, MD, PhD
Close
Sort by
Journal Articles

High Early Death Rate with Excellent Survival Beyond Day 30 in Acute Promyelocytic Leukemia Confirmed in Unselected Patients: Results of a Population-Based Registry Study

Jan M. Norgaard, MD, PhD, Lene Sofie Granfeldt Ostgard, MD, Eigil Kjeldsen, MD, Mette S. Holm, MD, PhD, Lars Kjeldsen, MD, PhD, Maria Kallenbach, MD, Marianne T. Severinsen, MD, PhD, Preben Johansen, MD, Lone S. Friis, MD, PhD, Duruta Weber, MD, PhD, Gitte Kerndrup, Birgitte Preiss, MD, Morten K. Jensen, MD, Inge H. Dufva, MD, Susanne Timshel, MD, Mette K. Andersen, MD, PhD, Ove J. Nielsen, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3542.
https://doi.org/10.1182/blood.V120.21.3542.3542
Published: 2012
Journal Articles

Extramedullary Leukemia and Myeloid Sarcoma in AML: Results From a Population-Based Registry Study of 2261 Patients

Lene S.G. Oestgaard, MD, Henrik Sengeloev, MD, PhD, Mette S. Holm, MD, PhD, Hans E. Johnsen, Marianne T. Severinsen, MD, PhD, Eigil Kjeldsen, MD, Olav J. Bergmann, MD, PhD, Lone S. Friis, MD, PhD, Morten K. Jensen, MD, PhD, Ove J. Nielsen, MD, PhD, Lars Kjeldsen, MD, PhD, Jan M. Norgaard, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2003.
https://doi.org/10.1182/blood.V118.21.2003.2003
Published: 2011
Journal Articles

Impaired CD163 Mediated Hemoglobin-Scavenging and Hemolytic Crisis in Patients Treated with CD33 Targeted Chemotherapy (Gemtuzumab Ozogamicin, Mylotarg™).

Maciej B. Maniecki, MHSc, Henrik Hasle, MD, PHD, Lennart Friis-Hansen, MD, PHD, Birgitte Lausen, MD, PHD, Ove J. Nielsen, MD, PHD, Knud Bendix, MD, PHD, Soren K. Moestrup, MD, PHD, Holger J. Moller, MD, PHD
Journal: Blood
Blood (2007) 110 (11): 3684.
https://doi.org/10.1182/blood.V110.11.3684.3684
Published: 2007